Roivant Sciences Ltd.
ROIV
71 insider filings · Latest: Oct 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2025 | Sep 22 8:20 PM | ERIC VENKER | Proposed Sale | 316,182 | $14.99 | $4.7M | — | View → |
| Sep 22, 2025 | Sep 22 8:07 PM | Venker Eric | Proposed Sale | 100,000 | $15.01 | $1.5M | — | View → |
| Sep 19, 2025 | Sep 19 8:32 PM | ERIC VENKER | Proposed Sale | 683,818 | $14.95 | $10.2M | — | View → |
| Aug 20, 2025 | Aug 20 8:30 PM | Venker Eric | Proposed Sale | 100,000 | $11.72 | $1.2M | — | View → |
| Jul 21, 2025 | Jul 21 8:34 PM | Venker Eric | Proposed Sale | 100,000 | $11.52 | $1.2M | — | View → |
| Jun 20, 2025 | Jun 20 8:35 PM | Ramaswamy Vivek | Proposed Sale | 577,007 | $11.46 | $6.6M | — | View → |
| Jun 20, 2025 | Jun 20 8:13 PM | Venker Eric | Proposed Sale | 100,000 | $11.45 | $1.1M | — | View → |
| Jun 18, 2025 | Jun 18 8:38 PM | Ramaswamy Vivek | Proposed Sale | 565,266 | $11.45 | $6.5M | — | View → |
| Jun 6, 2025 | Jun 6 8:33 PM | Ramaswamy Vivek | Proposed Sale | 200,800 | $11.19 | $2.2M | — | View → |
| Jun 4, 2025 | Jun 4 8:42 PM | Ramaswamy Vivek | Proposed Sale | 547,430 | $11.34 | $6.2M | — | View → |
| Jun 3, 2025 | Jun 3 9:14 PM | ERIC VENKER | Proposed Sale | 566,278 | $11.22 | $6.4M | — | View → |
| Jun 2, 2025 | Jun 2 8:16 PM | ERIC VENKER | Proposed Sale | 433,722 | $11.07 | $4.8M | — | View → |
| May 20, 2025 | May 20 8:30 PM | Venker Eric | Proposed Sale | 100,000 | $10.95 | $1.1M | — | View → |
| May 7, 2025 | May 7 8:37 PM | Ramaswamy Vivek | Proposed Sale | 625,000 | $11.18 | $7.0M | — | View → |
| May 6, 2025 | May 6 8:21 PM | Ramaswamy Vivek | Proposed Sale | 273,959 | $11.47 | $3.1M | — | View → |
| Apr 21, 2025 | Apr 21 7:22 PM | Venker Eric | Proposed Sale | 100,000 | $10.22 | $1.0M | — | View → |
| Mar 20, 2025 | Mar 20 9:27 PM | Venker Eric | Proposed Sale | 650,000 | $10.95 | $7.1M | — | View → |
| Mar 20, 2025 | Mar 20 7:54 PM | Venker Eric | Proposed Sale | 100,000 | $11.11 | $1.1M | — | View → |
| Feb 20, 2025 | Feb 20 8:35 PM | Venker Eric | Proposed Sale | 100,000 | $10.65 | $1.1M | — | View → |
| Feb 13, 2025 | Feb 18 5:15 PM | Kumar Rakhi | Proposed Sale | 227,500 | $10.43 | $2.4M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | Jun 29 10:23 PM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 500,000 | $3.85 | 14,724,363(D) | View → |
| Jun 24, 2026 | Jun 26 10:13 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 4,244,834(D) | View → |
| May 22, 2026 | May 22 10:25 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 4,444,834(D) | View → |
| Apr 20, 2026 | Apr 22 10:27 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 4,644,834(D) | View → |
| Apr 20, 2026 | Apr 22 10:26 PM | Richard PulikCFO | Grant/Award | 84,026 | $29.08 | 84,026(D) | View → |
| Apr 20, 2026 | Apr 22 10:26 PM | Jennifer HumesChief Accounting Officer | Grant/Award | 27,157 | $29.08 | 27,157(D) | View → |
| Mar 30, 2026 | Apr 1 11:20 PM | Matthew GlineDirector, CEO | Option Exercise | 2,178,150 | — | 0(D) | View → |
| Mar 30, 2026 | Apr 1 11:19 PM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 1,306,889 | — | 0(D) | View → |
| Mar 26, 2026 | Mar 31 1:01 AM | Meghan FitzgeraldDirector | Option Exercise | 70,000 | $8.80 | 48,578(D) | View → |
| Mar 17, 2026 | Mar 19 10:36 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 4,844,834(D) | View → |
| Feb 23, 2026 | Feb 24 1:40 AM | Frank TortiPresident and Vant Chair | Option Exercise | 587,390 | $3.85 | 3,026,184(D) | View → |
| Feb 20, 2026 | Feb 24 1:40 AM | Frank TortiPresident and Vant Chair | Option Exercise | 1,012,610 | $3.85 | 3,613,574(D) | View → |
| Feb 19, 2026 | Feb 24 1:40 AM | Frank TortiPresident and Vant Chair | Option Exercise | 1,400,000 | $3.85 | 4,626,184(D) | View → |
| Feb 13, 2026 | Feb 18 10:57 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 5,044,834(D) | View → |
| Feb 9, 2026 | Feb 11 10:53 PM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 651,558 | $12.68 | 0(D) | View → |
← Previous
Page 2 of 2